STOCK TITAN

Vanguard lists zero holdings in iRhythm (NASDAQ: IRTC)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting 0 shares of iRhythm Holdings Inc. common stock as of 03/13/2026. The filing explains an internal realignment on January 12, 2026 that caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports zero beneficial ownership after an internal reorganization.

The filing lists 0 shares beneficially owned and 0% of the class as of 03/13/2026. It attributes the change to an internal realignment on January 12, 2026 and states certain subsidiaries will report separately.

Cash‑flow treatment and trading intent are not described; subsequent filings may show new subsidiary-level positions. This amendment is administrative and does not, by itself, indicate a change in economic exposure reported at the subsidiary level.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Vanguard report for iRhythm (IRTC) in Amendment No. 7?

Vanguard reports 0 shares of iRhythm common stock as of 03/13/2026. The amendment explains an internal realignment on January 12, 2026 that caused certain subsidiaries to report ownership separately from The Vanguard Group, Inc.

Does the filing explain why ownership changed for IRTC?

Yes. The filing states Vanguard underwent an internal realignment on January 12, 2026, resulting in subsidiaries and business divisions reporting beneficial ownership separately. It says those entities pursue the same investment strategies as before the realignment.

Who signed the Schedule 13G/A amendment for IRTC?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with the signature date of 03/26/2026. The signature certifies the reporting information on behalf of The Vanguard Group.

Does the amendment show any Vanguard entities still hold IRTC shares?

This amendment reports aggregate beneficial ownership for The Vanguard Group as 0 shares and 0%. It notes certain subsidiaries will report separately, but does not list subsidiary-level holdings in this excerpt.
iRhythm Holdings, Inc

NASDAQ:IRTC

View IRTC Stock Overview

IRTC Rankings

IRTC Latest News

IRTC Latest SEC Filings

IRTC Stock Data

3.94B
31.74M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
San Francisco